Organon says FDA accepts Miudella IUD sNDA for 6-year use review

• FDA accepted for review an sNDA seeking to extend MIUDELLA copper IUD use to 6 years.
• PDUFA action date expected in Q2 2027.
• Organon licensed global rights from Sebela Women’s Health in June 2026; US commercial launch expected in late 2026.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Organon & Co. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260914839018) on September 14, 2026, and is solely responsible for the information contained therein.